There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for ...

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it ...

Third Harmonic Bio ( NASDAQ: THRD) will be liquidating the company and selling its remaining assets, the company said on ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody placulumab, and positive results from the phase 3 studies of remibrutinib.

It can transition into chronic urticaria for up to 8% of the population. Hives tend to go away without treatment, but ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

The following is a summary of “Dupilumab Improves Urticaria-Specific Quality of Life in Patients with Chronic Spontaneous ...

PALO ALTO, CA, USA I April 15, 2025 I Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated ...

you may have chronic hives. In this case, it may be helpful to speak with a board certified dermatologist to identify suitable treatment options. It isn’t always possible to prevent hives.